Previous close | 3.7200 |
Open | 3.8000 |
Bid | 3.6400 x 200 |
Ask | 3.7000 x 100 |
Day's range | 3.6350 - 3.9300 |
52-week range | 2.3600 - 7.2230 |
Volume | |
Avg. volume | 198,830 |
Market cap | 111.041M |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript March 19, 2024 Relmada Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.84, expectations were $-0.88. RLMD isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and […]
Q4 2023 Relmada Therapeutics Inc Earnings Call
Progress in CNS Treatments Amid Financial Challenges